Tretinoin for the treatment of cutaneous graft-versus-host disease
Gryn, J.; Crilley, P.
Bone Marrow Transplantation 5(4): 279-280
1990
ISSN/ISBN: 0268-3369 PMID: 2104506 Document Number: 353775
Chronic graft-versus-host disease (GVHD) of the skin is a common complication of allogeneic bone marrow transplantation. It can be resistant to common methods of systemic immunosuppression. We report successful treatment of a patient with progressive cutaneous GVHD that was resistant to cyclosporine and steroids after allogeneic marrow transplantation for acute myelogenous leukemia using topical tretinoin (Retin-A).
Document emailed within 1 workday
Related Documents
Breathnach, S.M.; Katz, S.I. 1983: Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease Journal of Immunology 131(6): 2741-2745Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
Via, C.S.; Rus, V.; Gately, M.K.; Finkelman, F.D. 1994: IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease Journal of Immunology 153(9): 4040-4047
Atkinson, K.; Storb, R.; Weiden, P.L.; Deeg, H.J.; Gerhard-Miller, L.; Thomas, E.D. 1980: In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: evidence that clonal abortion maintains stable graft-host tolerance Journal of Immunology 124(4): 1808-1814
Goyal, P.K.Kathuria.; Xu, S.; Choi, J. 2017: Delayed presentation of toxic epidermal necrolysis-like cutaneous acute graft-versus-host disease in the setting of recent immunosuppressant discontinuation Dermatology Online Journal 23(10)
Chen, Y.-B. 2019: New treatment options for the management of acute graft-versus-host disease Clinical Advances in Hematology and Oncology: H&o 17(9): 482-485
Herve, P. 1991: Perspectives in the prevention and treatment of acute graft versus host disease Bone Marrow Transplantation 7 Suppl. 2: 117-119
Besnier, D.P.; Chabannes, D.; Mahé, B.; Mussini, J.M.; Baranger, T.A.; Muller, J.Y.; Milpied, N.; Esnault, V.L. 1997: Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study Transplantation 64(1): 49-54
Owsianowski, M.; Gollnick, H.; Siegert, W.; Schwerdtfeger, R.; Orfanos, C.E. 1994: Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis Bone Marrow Transplantation 14(5): 845-848
Frezza, E.E.; Gerunda, G.E.; Fassina, A.; DeFranchis, R.; Biffi, R.; Gurakar, A.; Fagiuoli, S.; Maffei, F.A.; Van Thiel, D.H. 1994: NK activity during graft-vs-host disease and graft rejection in rats following intestinal transplantation Transplantation Proceedings 26(3): 1626
Jansen, J.; Goselink, H.M.; Veenhof, W.F.; Zwaan, F.E.; Blotkamp, C. 1983: The impact of the composition of the bone marrow graft on engraftment and graft-versus-host disease Experimental Hematology 11(10): 967-973
You-Ten, K.E.; Lapp, W.S. 1996: The role of endogenous glucocorticoids on host T cell populations in the peripheral lymphoid organs of mice with graft-versus-host disease Transplantation 61(1): 76-83
Dey, B.; Yang, Y.G.; Preffer, F.; Shimizu, A.; Swenson, K.; Dombkowski, D.; Sykes, M. 1999: The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model Transplantation 68(1): 141-149
Haanen, C.; De Witte, T.; Plas, A.; Schattemberg, T. 1991: Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation Haematologica 76 Suppl. 1: 22-28
Liem, L.M.; van Noort, J.T.; Goulmy, E. 1996: Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin a Bone Marrow Transplantation 18(1): 73-78
Deeg, H.J.; Storb, R. 1986: Acute and chronic graft-versus-host disease: clinical manifestations, prophylaxis, and treatment Journal of the National Cancer Institute 76(6): 1325-1328
Bishara, A.; Amar, A.; Brautbar, C.; Condiotti, R.; Lazarovitz, V.; Nagler, A. 1995: The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Experimental Hematology 23(14): 1667-1675
Sullivan, K.M.; Siadak, M.F.; Witherspoon, R.P. 1990: Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation Transplantation Proceedings 22(3): 1336-1338
Lu, J.; Xu, L.-p.; Huang, X.-j.; Chen, H.; Zhang, Y.-c.; Ren, H.-y.; Guo, N.-l.; Lu, D.-p. 2003: Treatment of severe steroid-refractory graft-versus-host disease with IL-2R alpha chain (CD25) monoclonal antibody Zhonghua Yi Xue Za Zhi 83(3): 216-219